Vanguard Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,240,391
Closed -$28M 4179
2018
Q3
$28M Buy
8,240,391
+194,437
+2% +$661K ﹤0.01% 2421
2018
Q2
$30.3M Buy
8,045,954
+278,315
+4% +$1.05M ﹤0.01% 2377
2018
Q1
$31.8M Sell
7,767,639
-126,220
-2% -$516K ﹤0.01% 2311
2017
Q4
$36.7M Buy
7,893,859
+328,889
+4% +$1.53M ﹤0.01% 2224
2017
Q3
$53.7M Buy
7,564,970
+366,701
+5% +$2.6M ﹤0.01% 2009
2017
Q2
$52M Buy
7,198,269
+349,521
+5% +$2.53M ﹤0.01% 1998
2017
Q1
$42.2M Buy
6,848,748
+302,986
+5% +$1.87M ﹤0.01% 2090
2016
Q4
$38.4M Buy
6,545,762
+146,770
+2% +$860K ﹤0.01% 2104
2016
Q3
$34M Buy
6,398,992
+197,290
+3% +$1.05M ﹤0.01% 2113
2016
Q2
$41.1M Sell
6,201,702
-125
-0% -$827 ﹤0.01% 1991
2016
Q1
$29M Buy
6,201,827
+199,730
+3% +$933K ﹤0.01% 2125
2015
Q4
$30.3M Sell
6,002,097
-1,112,591
-16% -$5.62M ﹤0.01% 2124
2015
Q3
$25M Buy
7,114,688
+245,837
+4% +$865K ﹤0.01% 2187
2015
Q2
$68.6M Buy
6,868,851
+336,631
+5% +$3.36M ﹤0.01% 1765
2015
Q1
$83.2M Buy
6,532,220
+841,982
+15% +$10.7M 0.01% 1625
2014
Q4
$80.5M Buy
5,690,238
+99,499
+2% +$1.41M 0.01% 1559
2014
Q3
$76.9M Buy
5,590,739
+1,430,465
+34% +$19.7M 0.01% 1542
2014
Q2
$64M Buy
4,160,274
+40,094
+1% +$617K 0.01% 1707
2014
Q1
$70.2M Buy
4,120,180
+1,658,084
+67% +$28.3M 0.01% 1598
2013
Q4
$31.9M Buy
2,462,096
+167,368
+7% +$2.17M ﹤0.01% 1993
2013
Q3
$23.2M Buy
2,294,728
+32,955
+1% +$333K ﹤0.01% 2060
2013
Q2
$16.9M Buy
+2,261,773
New +$16.9M ﹤0.01% 2126